Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 3 July 2023 31 July 2024 31 July 2024 14975216 Prof Jean Abraham Mr Nicholas Blake iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14975216 2023-07-02 14975216 2024-07-31 14975216 2023-07-03 2024-07-31 14975216 frs-core:CurrentFinancialInstruments 2024-07-31 14975216 frs-bus:PrivateLimitedCompanyLtd 2023-07-03 2024-07-31 14975216 frs-bus:FilletedAccounts 2023-07-03 2024-07-31 14975216 frs-bus:Micro-entities 2023-07-03 2024-07-31 14975216 frs-bus:AuditExempt-NoAccountantsReport 2023-07-03 2024-07-31 14975216 frs-bus:Director1 2023-07-03 2024-07-31 14975216 frs-bus:Director2 2023-07-03 2024-07-31
Registered number: 14975216
Indigo.Bio Ltd
Unaudited Financial Statements
For the Period 3 July 2023 to 31 July 2024
Watermill Accounting Limited
Balance Sheet
Registered number: 14975216
31 July 2024
£
Current assets 4,069
Creditors: Amounts Falling Due Within One Year (5,000 )
NET CURRENT LIABILITIES (931 )
TOTAL ASSETS LESS CURRENT LIABILITIES (931 )
Accruals and deferred income (540 )
NET LIABILITIES (1,471 )
CAPITAL AND RESERVES (1,471 )

Notes

1. General Information
Indigo.Bio Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14975216 . The registered office is 167-169 Great Portland Street, 5th Floor, London, W1W 5PF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Nicholas Blake
Director
27/03/2025